Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

52.51
Delayed Data
As of Sep 22
 +1.08 / +2.10%
Today’s Change
37.38
Today|||52-Week Range
52.60
+36.71%
Year-to-Date
Top Stock Reports for Caterpillar, Texas Instruments & Alphabet
Sep 22 / Zacks.com - Paid Partner Content
Abbott Labs Declares Quarterly dividend
Sep 17 / GuruFocus News - Paid Partner Content
Here's Why You Should Add Abbott (ABT) to Your Portfolio Now
Sep 22 / Zacks.com - Paid Partner Content
Abbott's (ABT) FreeStyle Libre Gets UK Reimbursement Nod
Sep 14 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close51.43
Today’s open51.51
Day’s range51.50 - 52.58
Volume7,978,960
Average volume (3 months)5,765,910
Market cap$91.2B
Dividend yield2.02%
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-47.25%
Earnings growth (this year)+13.02%
Earnings growth (next 5 years)+11.65%
Revenue growth (last year)+2.20%
P/E ratio82.0
Price/Sales2.73
Price/Book3.77

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.58+0.70%
NVONovo Nordisk+0.16+0.33%
GSKGlaxoSmithKline+0.25+0.62%
BMYBristol-Myers Squibb+0.03+0.05%
Data as of 4:02pm ET, 09/22/2017

Financials

Next reporting dateOctober 18, 2017
EPS forecast (this quarter)$0.65
Annual revenue (last year)$20.9B
Annual profit (last year)$1.4B
Net profit margin5.06%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Executive VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts